Logo

 

Our Mission
Founders

Daniel Bertrand

Neuroscientist worldwide-recognized for its contribution in the field of physiology and pharmacology of neuronal nicotinic acetylcholine receptors.

Sonia Bertrand

Senior technician skilled in molecular biology and electrophysiology. During the past fifteen years she contributed to all major publications on the work of neuronal nicotinic acetylcholine receptors and her knowledge in this field is worldwide recognized.

Reto Stöcklin

PhD in medical biochemistry, he is specialized in protein chemistry, mass spectrometry, proteomics and biocomputing. Owner and head of Atheris Laboratories, a company he founded in Geneva in 1995, which focuses primarily on research and development in life sciences.

Peter Leuenberger

MD specialized in ophthalmology surgery he was for several years Professor at the Medical Faculty in Geneva and he is president of the A. Vogt foundation.
HiQScreen will be the first company using fully automated functional screening to test the action of compounds at membrane proteins. The aims is to offer pharmaceutical companies functional screening of large scale compound libraries. The technology established in Geneva under patent application exploits a new concept for drug application. HiQScreen technology will fill a new market niche and aims to become a worldwide leader in functional screenin